The first trimester: prediction and prevention of the great obstetrical syndromes

Arianne Sweeting1, Felicity Park2, Jon Hyett3

  • 1Faculty of Medicine, University of Sydney, Sydney, NSW, Australia; Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Insights

Screening for pre-eclampsia and gestational diabetes in the first trimester shows promise. Early detection through combined screening methods may improve maternal and neonatal outcomes by enabling timely therapeutic interventions.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Reproductive Health

Background:

  • Current research explores early screening for pre-eclampsia and gestational diabetes at 12 weeks' gestation.
  • This aligns with existing first-trimester aneuploidy screening protocols.
  • Utilizing regression analysis to integrate demographic and investigative data is a key approach.

Purpose of the Study:

  • To evaluate the feasibility and potential of early screening for pre-eclampsia and gestational diabetes.
  • To assess the integration of this screening into first-trimester aneuploidy screening.
  • To identify methods for improving maternal and neonatal outcomes through early detection.

Main Methods:

  • Employing regression analysis to combine multiple demographic and investigative factors.
  • Integrating screening for pre-eclampsia and gestational diabetes with combined first-trimester screening for aneuploidy.
  • Analyzing data from early gestation (12 weeks).

Main Results:

  • Research into pre-eclampsia prediction is currently more robust.
  • Early screening holds potential for therapeutic intervention.
  • Improved maternal and neonatal outcomes are anticipated with effective early detection.

Conclusions:

  • First-trimester screening for pre-eclampsia and gestational diabetes is under investigation.
  • Robust prediction models for pre-eclampsia offer opportunities for intervention.
  • Early detection strategies aim to enhance maternal and neonatal health outcomes.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.7K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
16.1K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
48
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
5.0K